It is anticipated that the inflammatory disorders of the vaginal and vulval inflammatory diseases treatment market would grow from US$ 2.8 billion in fiscal year 2022 to US$ 2.96 billion in fiscal year 2023. Between 2023 and 2033, the global market is anticipated to expand at a 5.8% CAGR, peaking at US$ 5.21 billion by the …